Correction: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer by Wishart, Gordon C et al.
Following the publication of our article [1] we noticed an 
error in Table 1 relating to the number of patients who 
received adjuvant therapy. Th   e correct table is given here 
(Table 1).
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© 2010 BioMed Central LtdTable 1. Patient characteristics for model development (ECRIC) and validation (WMCIU) cohorts
   ECRIC    WMCIU 
Total Number of Subjects  5,694    5,468 
Total time at risk (years)  31,904    25,917 
Median follow-up (years)*  5.65  (0.04-8.00)†  4.85 (0.07-8.00)†
Number of breast cancer deaths  737    668 
Number of other deaths  338    287 
Annual breast cancer mortality rate  0.023  (0.021-0.025)‡  0.026 (0.024-0.028)‡
5-year breast cancer survival rate  0.89  (0.88-0.90)‡  0.88 (0.87-0.89)‡
Median age at diagnosis, years  58  (23-95)†  58 (22-93)†
    Number %  Number %
Age, years
    <35  111 2  108 2
  35-49  1,172 21  1,195 22
  50-64  2,630 46  2,393 44
  65-74  1,124 20  1,101 20
  75+  657 12  671 12
Nodal status
  0  3,532 62  3,184 58
  1  741 13  746 14
  2-4  806 14  792 14
  5-9  380 7  451 8
  10+  235 4  295 5
Tumour size, mm
 <10  625  11  485  9
  10-19  2,310 41  2,136 39
  20-29  1,627 29  1,566 29
  30-49  845 15  923 17
  50+  287 5  358 7
Grade
  I  1,005 18  1,017 19
  II  2,927 51  2,442 45
  III  1,762 31  2,009 37
ER Status
 ER  negative  991  17  1,116  20
  ER  positive  4,703 83  4,352 80
Adjuvant therapy
 None  643  11  1,520  28
 Chemotherapy  only  783  14  1,542  28
  Endocrine  therapy  3,146 55  1,827 33
 Combined  chemoendocrine  1,122  20  579  11
Screen detected
  Yes  1,621 28  1,256 23
  No  4,073 72  4,212 77
*Follow-up censored at 8 years
†Range of variable
‡95 CI
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